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Obstructive nephropathy in the neonatal rat is attenuated by epidermal
growth factor.
Background. Obstructive nephropathy is a primary cause of renal failure
in infancy. Chronic unilateral ureteral obstruction (UUO) in the neonatal
rat results in reduced renal expression of epidermal growth factor (EGF),
renal tubular epithelial (RTE) cell apoptosis and interstitial fibrosis. We
wished to determine whether these changes could be prevented by
exogenous administration of EGF.
Methods. Thirty-three Sprague-Dawley rats underwent UUO within the
first 48 hours of life, and received daily injections of either EGF (0.1
mg/kg/day) or saline (control) for the following seven days, after which
obstructed and intact opposite kidneys were removed for study. These
were compared to 11 sham-operated rats that received either no injec-
tions, EGF injections, or saline injections. Renal cell proliferation was
determined by proliferating cell nuclear antigen, apoptosis was measured
by the TUNEL technique, and the distribution of vimentin, clusterin,
transforming growth factor-beta 1 (TGF-b1), and a-smooth muscle actin
were determined by immunohistochemistry. Tubular dilation, tubular
atrophy, and interstitial collagen deposition were quantitated by histomor-
phometry.
Results. Compared to controls, EGF treatment increased RTE cell
proliferation in the obstructed kidney by 76%, decreased apoptosis by
80%, and reduced vimentin, clusterin and TGF-b1 immunostaining (all
P , 0.05). EGF treatment reduced tubular dilation by 50%, atrophic
tubules by 30%, and interstitial fibrosis by 50% (all P , 0.05). There was
no significant effect of EGF on renal alpha smooth muscle actin distribu-
tion. There was no effect of saline or EGF injections on kidneys from
sham-operated rats for any of the parameters studied.
Conclusions. We conclude that EGF stimulates RTE cell proliferation
and maturation and reduces apoptosis in the neonatal rat kidney subjected
to chronic UUO. These effects may contribute to the reduction in tubular
dilation, tubular atrophy, and interstitial fibrosis. By preserving renal
development, administration of EGF attenuates the renal injury resulting
from chronic UUO.
Congenital obstructive nephropathy is a primary cause of
renal failure in infancy and childhood [1]. Renal failure
results from the effects of urinary tract obstruction to delay
growth and maturation of the developing kidney [2]. Kid-
neys from midtrimester human fetuses with congenital
urinary tract obstruction have reduced nephrogenesis, cys-
tic changes, and interstitial fibrosis [3]. We have character-
ized a model of obstructive nephropathy in the neonatal
rat, a species in which only 10% of nephrons are present at
birth, and nephrogenesis is complete by 7 to 10 days of age
[4]. This period is analogous to that of the midtrimester
human fetus, during which the major features of obstruc-
tive nephropathy evolve [3]. Unilateral ureteral obstruction
(UUO) during the first 48 hours of life in the rat markedly
impairs renal growth and delays renal maturation [5]. In
addition, renal cell proliferation is decreased, while apo-
ptosis (programmed cell death) is increased in the devel-
oping obstructed kidney [6]. The end result of chronic
UUO in the neonatal rat is tubular atrophy and diffuse
interstitial fibrosis [7].
We have demonstrated that one of the consequences of
chronic UUO in the neonatal rat is a marked suppression
of expression of renal prepro-epidermal growth factor
(EGF) mRNA [5]. This is reflected by a suppression of
renal tubular immunoreactive EGF in 14-day-old rats
subjected to UUO [7]. EGF is a peptide growth factor
expressed in the rat kidney beginning at approximately the
third postnatal day, and with steadily increasing expression
during the first month of life [5]. EGF has been shown to
act as a potent mitogen for renal tubular epithelial (RTE)
cells [8]. In addition, exposure of the normally developing
metanephric kidney to EGF significantly reduces the rate
of endogenous apoptosis that contributes to renal remod-
eling [9]. Moreover, short-term (24 to 72 hr) administration
of EGF to adult rats with UUO increases mitoses and
reduces apoptosis in the obstructed kidney [10].
There are a number of parallels between the response of
the developing kidney to UUO, and the renal changes
resulting from cystic kidney disease, as well as the renal
response to ischemia. All are characterized by an activation
of the renin-angiotensin system, tubular dilation, tubular
atrophy, activation of tubular apoptosis, and tubular ex-
pression of clusterin, a dimeric glycoprotein expressed in a
variety of forms of renal injury [7]. In addition, expression
of EGF is reduced in both cystic and ischemic renal disease
[11, 12]. A recent study has shown that exogenous EGF can
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significantly improve glomerular filtration rate, reduce ap-
optosis, and reduce tubular dilation in mice with experi-
mental cystic kidney disease [13]. Moreover, administration
of exogenous EGF to rats with ischemic nephropathy also
ameliorates recovery by improving cell regeneration and
repair [14]. We wished to test the hypothesis that prolonged
exogenous administration of EGF to neonatal rats could
maintain renal development and attenuate the interstitial
fibrosis and tubular atrophy resulting from chronic UUO.
The present study extends the observations of 24 to 72
hours administration of EGF to adult rats with UUO [10]
by examining the long-term consequences of EGF on the
neonatal obstructed kidney. The results show a dramatic
effect of exogenous EGF to attenuate the injurious effects
of UUO on the developing kidney.
METHODS
Animal preparation
Forty-four newborn Sprague-Dawley rats were subjected
to complete left ureteral obstruction or sham-operation
within the first 48 hours of life. Under general anesthesia
with halothane and oxygen, the distal ureter was exposed
and ligated (or left untouched) through a small abdominal
incision with a silk suture. The incision was closed in a
single layer and coated with collodion. The animals were
then allowed to recover from anesthesia and were returned
to their mothers. One day after surgery, 20 rats were
injected subcutaneously with EGF (Upstate Biotechnology,
Lake Placid, NY, USA) for seven days at a daily dose of 0.1
mg/kg body wt. Twenty rats were injected subcutaneously
with saline vehicle, to serve as controls. An additional
group of four sham-operated rats received no injections, to
control for the effect of injection. Rats were sacrificed eight
days after operation, and kidneys were removed, decapsu-
lated, weighed, and processed for histologic study.
Morphometric analysis
Kidneys were fixed in 10% phosphate buffered formalin,
dehydrated through graded alcohol and xylene, embedded
in paraffin, sectioned at 5 mm, and stained with Masson
trichrome stain or periodic acid Schiff (PAS).
Renal interstitial collagen distribution. Sections were ex-
amined by light microscopy under 3400 magnification, and
ten nonoverlapping fields containing cortex and medulla
were examined for each kidney. Using image analysis
software (Mocha 1.2; Jandel Scientific, San Rafael, CA,
USA), digital images of the Masson trichrome stained
sections were superimposed on a grid, and the number of
grid points overlapping interstitial blue-staining collagen
was recorded for each field.
Tubular luminal area. Sections were examined under
3400 magnification, and ten nonoverlapping fields were
scanned for each kidney. Tubular luminal areas were
recorded for each field of the Masson trichrome stained
sections.
Tubular atrophy. PAS-stained kidney sections were exam-
ined under 3400 magnification, and the number of atro-
phic tubules was quantitated in 10 nonoverlapping fields.
Atrophic tubules were identified by thickened basement
membranes.
Immunohistochemistry
Immunohistochemical localization was performed on
formalin fixed, paraffin-embedded tissue using the avidin-
biotin immunoperoxidase method (Vectastain ABC Kit;
Vector Laboratories, Burlingame, CA, USA). The primary
antibodies used were monoclonal mouse anti-rat prolifer-
ating cell nuclear antigen (PCNA) diluted 1:150 in phos-
phate buffered saline (PBS; Vector Laboratories), mono-
clonal mouse anti-human vimentin (1:650; Sigma Chemical
Co., St. Louis, MO, USA), monoclonal rabbit anti-rat
clusterin (1:50; Upstate Biotechnology, Lake Placid, NY,
USA), monoclonal anti-a-smooth muscle-specific actin (1:
400; Sigma Chemical Co.), and polyclonal rabbit anti-
human TGF-b1 (1:100; Promega, Madison, WI, USA).
Selected serial sections were treated for 30 minutes with
biotinylated forms of Dolichos biflorus agglutinin (1:400)
or Lotus tetragonolobus lectin (1:25; Vector Laboratories)
to identify collecting ducts or proximal tubules, respec-
tively. Sections were counterstained with Gill’s #2 hema-
toxylin, dehydrated and mounted for examination by light
microscopy. As a negative control, the primary antiserum
was replaced by nonimmune rabbit serum and no staining
occurred.
Apoptotic nuclei. Apoptotic nuclei were labeled using the
Tdt uridine-nick-end-label (TUNEL) technique (Apoptag;
Oncor, Gaithersburg, MD, USA). Histologic sections were
digested for eight minutes in proteinase K, 20 mg/ml, and
washed in distilled water. Endogenous peroxidase was
quenched with 2% hydrogen peroxide in PBS methanol for
10 minutes, and samples were exposed to digoxigenin11-
dUTP using terminal deoxynucleotidyl transferase (Tdt)
(1:5) for one hour at 37°C. Samples were rinsed in PBS,
blocked with 1% globulin-free bovine serum albumin for 15
minutes, treated with anti-digoxigenin peroxidase FAB
fragments (Oncor), and incubated for 30 minutes at room
temperature. Color was developed using 0.07% diamino-
benzidine and 0.02% hydrogen peroxide for five minutes.
Sections were counterstained with hematoxylin, dehydrated
in graded alcohol, and examined by light microscopy.
Kidneys were examined by light microscopy at 3400
magnification. Ten nonoverlapping fields were scanned and
for sections stained for PCNA or apoptosis, the number of
labeled tubular and interstitial cells was counted in each
field. A semiquantitative method was used to examine the
interstitial cellular staining of a-smooth muscle actin and
vimentin, and the tubular cell staining of clusterin, TGF-b1,
and vimentin. A scale from 1 (no staining) to 3 (maximal
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staining) was used to assess immunostaining in the kidney
sections. For each antibody, the results were normalized to
the score for the intact kidney of vehicle (saline) treated
rats. All histomorphometry and immunohistochemical de-
terminations were performed with the observer blinded to
the treatment group.
Statistical analysis
Data are presented as mean 6 standard error. Compar-
isons between groups were made using one-way analysis of
variance followed by the Student-Newman-Kuels test.
Comparisons between left and right kidneys were per-
formed using the Student’s t-test for paired data. Statistical
significance was defined as P , 0.05.
RESULTS
The relative survival of rats receiving EGF was 79%,
which did not differ from that of animals receiving saline
vehicle (88%). Administration of EGF reduced body wt by
14% in rats undergoing UUO (14.7 6 0.6 g vs. 17.2 6 0.5 g,
P , 0.05), and by 18% in rats undergoing sham operation
(17.3 6 0.6 vs. 21.2 6 0.4 g, P , 0.05; Table 1). Daily saline
vehicle injections did not affect body wt in sham-operated
animals (Table 1). Kidney weight was proportional to body
wt, such that the kidney/body wt ratio for control versus
EGF groups was not different for either obstructed (6.1 6
0.4 vs. 5.8 6 0.2) or intact kidneys (6.1 6 0.2 vs. 5.2 6 0.4).
There was no effect of injections or of EGF on kidney/body
wt ratio in sham-operated rats (Table 1). Renal tubular
epithelial cell proliferation, as measured by PCNA labeling,
was reduced by ipsilateral UUO compared to the intact
kidney (Figs. 1A, B and 2 A, B). However, administration
of EGF increased RTE cell proliferation in the obstructed
kidney and reduced proliferation in the intact opposite
kidney (Fig. 2A). The sum of proliferating RTE cells for
the combined left and right kidneys did not differ between
groups (P not significant). Interstitial cell proliferation was
increased in obstructed compared to intact kidneys (P ,
0.05; Fig. 2B), but the proliferative activity was markedly
less than that of RTE cells in either kidney (Fig. 2A).
Administration of EGF reduced interstitial cell prolifera-
tion in the obstructed kidney, and did not affect cell
proliferation in the intact kidney (Fig. 2B). There was no
significant effect of saline or EGF injections on renal
tubular cell proliferation in sham-operated rats (Table 1).
There were only occasional PCNA-positive nuclei in the
interstitium of sham-operated rats regardless of treatment
(data not shown).
Ureteral obstruction stimulated RTE cell apoptosis. As
illustrated in Figure 1C, brown-staining tubular cells man-
ifest the characteristics of apoptosis, including condensed
nuclei with cytoplasmic “blebs.” As shown in Figure 2C,
compared to the intact kidney, UUO increased the number
of apoptotic RTE cells by over 30-fold (P , 0.05). Admin-
istration of EGF reduced the number of apoptotic RTE
cells in the obstructed kidney by 80% (Figs. 1D and 2C).
The number of apoptotic interstitial cells was also greater
in the obstructed compared to the intact opposite kidney
(P , 0.05), and EGF treatment reduced the population of
apoptotic cells (Fig. 2D). There was no significant effect of
saline or EGF injections on renal tubular cell apoptosis in
sham-operated rats (Table 1). There were only occasional
apoptotic nuclei in the interstitium of sham-operated rats
regardless of treatment (data not shown).
Compared to the intact kidney, chronic UUO resulted in
marked accumulation of interstitial collagen (P , 0.05;
Figs. 1E and 2E). This was reduced by over 50% following
the administration of EGF (Figs. 1F and 2E).
Vimentin is a microfilament protein expressed by mes-
enchymal, but not by normal, polarized epithelial cells.
Compared to the intact kidney, in which vimentin was not
expressed by tubular cells, UUO induced RTE cell vimen-
tin immunostaining in scattered tubules (Fig. 3A). This
increased expression of vimentin was significantly reduced
by EGF administration (Fig. 4A).
Clusterin is a dimeric glycoprotein that is expressed by
distal renal tubular cells in response to injury. Compared to
the intact kidney, in which clusterin was not expressed by
tubular cells, UUO induced clusterin immunostaining in
scattered tubules (Fig. 3B). Tubular clusterin expression
was significantly reduced by EGF administration (Fig. 4B).
Renal tubular cell expression of TGF-b1, a fibrogenic
cytokine, was increased in the obstructed kidney (Fig. 3C).
Immunoreactive TGF-b1 in the obstructed kidney was
significantly reduced by EGF treatment (Fig. 4C).
Alpha-smooth muscle actin is a contractile protein nor-
mally expressed by vascular smooth muscle cells, as well as
by interstitial cells during the first week of life in the rat
[15]. Whereas interstitial expression of immunoreactive
a-smooth muscle actin had disappeared by 10 days of life in
the intact kidney (not shown), it was significantly increased
by chronic UUO (Fig. 3D). While administration of EGF
tended to reduce the expression of interstitial a-smooth
muscle actin in the obstructed kidney, this was not statisti-
cally significant (Fig. 4D). As shown in Figures 3E and 4E,
compared to the intact kidney, UUO caused marked
dilation of a majority of tubules (P , 0.05). Administration
of EGF reduced the degree of tubular dilation in the
obstructed kidney by over 50% (Fig. 4E). As shown in
Table 1. Characteristics of sham-operated rats
No treatment Saline EGF
Number of rats 4 4 3
Body weight (g) 20.4 6 0.4 21.2 6 0.4 17.3 6 0.6a
Left kidney/body wt 5.2 6 0.1 5.1 6 0.2 5.0 6 0.2
Right kidney/body wt 5.2 6 0.1 5.2 6 0.2 5.0 6 0.1
PCNA-staining tubular cells/field 79.8 6 48.9 99.2 6 21.5 86.8 6 6.6
Apoptotic tubular cells/field 1.0 6 1.0 2.0 6 0.6 1.7 6 1.7
Abbreviations are: EGF, epidermal growth factor; wt, weight; PCNA,
proliferating cell nuclear antigen.
a P , 0.05 vs. No treatment and Saline
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Fig. 1. Photomicrographs of representative obstructed (UUO) kidneys of neonatal rats. Control kidneys are shown on the left (A, C, E), and
EGF-treated kidneys on the right (B, D, F). (A and B) Proliferating cell nuclear antigen (PCNA). (C and D) Apoptotic nuclei identified by Tdt uridine
nick end label (TUNEL) technique. Labeling of cells in A-D is indicated by brown staining. (E and F) Interstitial collagen (blue) stained by Masson
trichrome.
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Figures 3F and 4F, compared to the intact kidney, UUO
increased the number of atrophic tubules by tenfold (P ,
0.05). The number of atrophic tubules in the obstructed
kidney was reduced by 33% following administration of
EGF (Fig. 4F).
Based on review of serial sections, proliferating (PCNA-
labeled) or vimentin-staining tubular cells were distributed
approximately equally between proximal tubules (binding
Lotus tetragolonobus) and collecting ducts (binding Doli-
chos biflorus). In contrast, the majority of apoptotic or
clusterin-staining tubular cells were localized to collecting
ducts. The colocalization of proliferating and apoptotic
cells in the obstructed kidney is shown in Figure 5.
DISCUSSION
The primary finding in the present study is the demon-
stration of a dramatic salutary effect of exogenous EGF on
the cellular response of the developing kidney to chronic
UUO. Whereas the approach to the pathophysiology of
obstructive nephropathy had for many years focused on the
hemodynamic consequences, the identification of a number
of growth factors active in the kidney has more recently
shifted attention to cellular events [7]. Thus, compared to
the adult, the rapidly growing neonatal rat kidney appears
to be particularly susceptible to interference with cellular
proliferation and stimulation of apoptosis as a result of
chronic UUO [6]. The mechanisms underlying these effects
are complex, involving the interaction of multiple growth
factors and cytokines.
The RTE cell appears to play a central role in the
response to UUO. As shown in the present study, suppres-
sion of cellular proliferation and stimulation of apoptosis
are primarily localized to the RTE cell. In response to
UUO, RTE cells undergo phenotypic transformation to
Fig. 2. Quantitation of cellular proliferation, apoptosis, and interstitial fibrosis in obstructed (UUO) and intact opposite kidney of control (M) and
EGF-treated (f) groups of rats. (A) PCNA-labeled renal tubular epithelial cells (N 5 4 each group). (B) PCNA-labeled interstitial cells (note different
scale compared to panel A). (C) Tubular apoptotic cells identified by the TUNEL technique (N 5 4 each group). (D) Interstitial apoptotic cells
identified by TUNEL technique. (E) Relative area of renal interstitial collagen deposition (N 5 6 each group). *P , 0.05 versus control treatment group;
#P , 0.05 versus UUO kidney, same treatment group.
Chevalier et al: EGF in neonatal obstructive nephropathy42
express vimentin, an intermediate filament protein pro-
duced by mesenchymal cells [16]. In preliminary studies, we
have shown that expression of vimentin by RTE cells occurs
following chronic obstruction of single nephrons by mi-
cropuncture [17]. In this regard, interstitial expression of
alpha smooth muscle actin is also localized around dilated
Fig. 3. Photomicrographs of representative obstructed (UUO) kidneys of control neonatal rats. (A) Immunoreactive vimentin distribution. Arrowheads
indicate brown-staining vimentin-positive renal tubular epithelial (RTE) cells. (B) Immunoreactive clusterin distribution. Apical borders of RTE cells
in dilated tubules contain brown-staining immunoreactive clusterin (*). (C) Immunoreactive transforming growth factor-beta 1 (TGF-b1) distribution.
Arrowheads indicate brown-staining TGF-b1-positive tubules. (D) Immunoreactive alpha smooth muscle actin distribution. Interstitial cells are
positively stained brown, whereas tubules are not. (E) Dilated tubules surrounded by pink-staining mesenchymal cells. (F) Atrophic tubules with
thickened tubular basement membranes (*).
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loops of chronically obstructed single nephrons [17]. This
suggests that the interstitial changes are also a consequence
of alterations in neighboring RTE cells. Most importantly,
the present study demonstrates that the renal consequences
of chronic UUO in the neonate (tubular dilation, tubular
atrophy, and interstitial fibrosis) are all attenuated by
administration of EGF. Since EGF receptors are localized
to RTE cells [18], this lends further support to the hypoth-
esis that the RTE cell plays a critical role in the mediation
of obstructive nephropathy. Chronic UUO reduced prolif-
eration of RTE cells in the neonatal obstructed kidney.
However, following EGF administration, RTE cell prolif-
eration in the intact opposite kidney decreased in concert
with an increase in cell proliferation in the obstructed
kidney. This would appear to be an example of counterbal-
ance, a concept originally developed by Hinman, in which
alterations in one kidney are balanced by compensatory
responses in the opposite organ [19]. Compared to the
adult, counterbalance is highly activated in early develop-
ment, including suppression of renin expression by the
intact kidney while renin expression is markedly activated
in the obstructed kidney [5]. By Northern analysis, EGF
mRNA is undetectable in the neonatal rat kidney until
three days of age [5], and renal immunoreactive EGF in the
mouse has reached less than 50% of adult levels by two
weeks of age [20]. Administration of EGF in a dose fivefold
Fig. 4. Effect of epidermal growth factor (EGF) on indices of renal injury following UUO. (A) Semiquantitative distribution of immunoreactive
vimentin in obstructed (UUO) kidney of each group. Shown is the relative number of vimentin-positive tubules per field (N 5 5 rats each group). (B)
Distribution of immunoreactive clusterin in obstructed kidney of each group. Shown is the relative number of clusterin-positive tubules per field (N 5
4 rats each group). (C) Distribution of immunoreactive transforming growth factor-beta 1 (TGF-b1) in obstructed kidney of each group. Shown is the
relative number of TGF-b1-positive tubules per field (N 5 5 rats each group). (D) Distribution of immunoreactive alpha-smooth muscle actin in
obstructed kidney of each group. Shown is the relative area of interstitial immunoreactive a-smooth muscle actin per field (N 5 4 rats each group). (E)
Relative mean tubular luminal area of each kidney of each group (N 5 6 control, N 5 9 EGF). (F) Relative number of atrophic tubules per field in
each kidney (N 5 6 per group). Shown are control (M) and EGF-treated (f) groups of rats;). *P , 0.05 versus control treatment group; #P , 0.05
versus UUO kidney, same treatment group.
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that used in the present study impairs kidney growth in the
newborn mouse [21]. It is possible that suppression of the
renin-angiotensin system in the intact kidney contributes to
a reduced effect of EGF on the intact opposite kidney.
In preliminary studies, we have shown that chronic UUO
results in redistribution of EGF receptors from the baso-
lateral to the apical surface of RTE cells [22]. Redistribu-
tion of EGF receptors to the apical cell surface has also
been found in cystic kidney disease, in which the density of
EGF receptors is also increased [23]. Thus, enhanced
access of EGF to its receptor may also contribute to the
response reported in the present study. In addition to its
proliferative actions, EGF also stimulates cellular differen-
tiation. Several lines of evidence suggest that tubular
dilation associated with cystic kidney disease results from
arrested differentiation of the RTE cell [24]. It is possible
that clusterin expression by RTE cells in cystic kidneys is a
consequence of dedifferentiation to a less mature stage
[25]. In this regard, UUO in the neonatal rat results in the
persistence of a number of markers of a less mature kidney,
including the expression of clusterin [5]. Administration of
EGF to RTE cells in vitro suppresses the expression of
clusterin [26]. Thus, by stimulating its differentiation, ex-
ogenous EGF may allow normal development of the RTE
cell, thereby reducing formation of tubular dilation in
either the cystic kidney or the obstructed kidney. Chronic
UUO stimulates greater clusterin expression in the adult
compared to the neonatal obstructed kidney [6], and EGF
reduces clusterin expression in RTE cells in vitro [26].
There are additional examples of congruence between
cystic kidney disease and obstructive nephropathy. Elegant
microdissection studies of chronic UUO in the fetal rabbit
Fig. 5. Serial sections of obstructed kidney (UUO) from a saline-treated rat. The same four tubular loops have been identified in each section. (A)
Apoptotic nuclei identified by the TUNEL technique. Tubules 1 and 3 contain positively stained cells. (B) Proliferating (PCNA-positive) cells are
localized also to tubules 1, 2, 3, and 4. (C) Dolichos biflorus lectin, a marker for collecting ducts, binds to tubules 2 and 4. (D) Lotus tetragolonobus
lectin, a marker for proximal tubules, binds to tubule 3.
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demonstrate focal dilation of the distal nephron resulting in
the formation of cysts, rather than dilation along the entire
length of the nephron [27]. Also using techniques of
microdissection, Tanner et al have shown recently focal
regions of tubular stenosis in nephrons from rats with cystic
kidney disease [28].
An additional action of EGF that may contribute to its
salutary effects in the obstructed kidney is its promotion of
RTE cell regeneration in vitro [29]. Thus, recovery of
confluency by cultured RTE cells exposed to nephrotoxi-
cants is markedly enhanced by exogenous EGF [30]. Others
have shown that EGF promotes recovery of confluency of
RTE cells following mechanical injury [29]. These findings
suggest a role for EGF in accelerating the process of
re-establishing a confluent, polarized epithelium by hasten-
ing the redifferentiation of RTE cells following transient
dedifferentiation to cells with mesenchymal characteristics.
The EGF-induced reduction in cellular expression of vi-
mentin in the obstructed kidney in the present study is
consistent with this hypothesis.
Growth and development are a net consequence of a
balance between cellular proliferation and apoptosis. EGF
has been shown to reduce apoptosis in vitro, as well as in
other models of tubular injury [13, 14, 30]. EGF has been
shown to inhibit apoptosis induced by transforming growth
factor-b1 (TGF-b1) in vitro [31]. This occurs by inhibition
of c-fos induction [31]. Since UUO in the neonatal rat
markedly increases expression of renal TGF-b1 [5], it is
likely that apoptosis is in part mediated by this cytokine,
and that EGF may act in part through this mechanism. In
addition to its action to inhibit apoptosis resulting from
withdrawal of growth factors, EGF has been shown to
oppose apoptosis resulting from oxidative injury in the
kidney [32]. UUO has been shown to result in renal
oxidative stress, which may be aggravated by insufficient
response by renal antioxidant enzymes [33, 34]. Thus, EGF
may reduce apoptosis at a point distal to the inciting
stimulus. Administration of EGF to adult rats with 24 to 72
hours of UUO reduces apoptosis by 50% [10], which is
comparable to the 80% reduction in apoptosis shown here
in the neonatal rat. It is likely that apoptosis of RTE cells
leads to tubular atrophy [35], in which case the effect of
EGF to reduce apoptosis may account for the reduction in
tubular atrophy in the present study.
In summary, chronic administration of EGF dramatically
attenuated the impairment of renal development in the
maturing rat kidney subjected to chronic UUO. RTE cell
proliferation was augmented, apoptosis was suppressed,
and RTE cell differentiation was restored. These cellular
changes had profound long-term consequences, notably a
reduction in tubular dilation, tubular atrophy, and intersti-
tial fibrosis. Further investigation of these phenomena may
elucidate the mechanisms underlying the regulation of
abnormal renal growth and development, and should lead
to new therapeutic approaches to congenital obstructive
nephropathy.
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APPENDIX
Abbreviations used in this article are: EGF, epidermal growth factor;
PAS, periodic acid Schiff; PBS, phosphate buffered saline; PCNA, prolif-
erating cell nuclear antigen; RTE, renal tubular epithelial cells; Tdt,
terminal deoxynucleotidyl transferase; TGF, transforming growth factor;
TUNEL, Tdt uridine-nick-end-label; UUO, unilateral ureteral obstruc-
tion.
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